The diagnostic and prognostic value of lncRNAs is gaining traction, with the PTTG3P/miR-192-3p/CCNB1 axis emerging as a potential biomarker for childhood asthma, underscoring their promise in non-invasive disease monitoring [57]. This evidence concerns the gene CCNB1 and childhood onset asthma.